2024 Aesthetics Industry Overview and Trends

This report presents an overview of the aesthetics industry for 2024, detailing market trends and spending patterns across various segments. It outlines the total U.S. non-surgical aesthetics spend projected to reach significant figures, with specific shares allocated to neurotoxins, dermal fillers, and energy-based devices. The report also highlights the average patient metrics, including acquisition and retention rates, as well as average spending per patient. Significant growth is noted in the neurotoxins and biostimulatory injectables markets, while energy-based devices show varied performance across segments. The analysis further discusses the adoption of GLP-1 medications in aesthetic practices, revealing their impact on revenue growth. Additionally, the report includes insights on professional-grade skincare and emerging therapies such as exosomal treatments, indicating a shift in consumer preferences and spending behavior. Overall, the document provides a comprehensive look at the evolving landscape of the aesthetics industry, supported by data and analytics from Qsight.